Slow Progress
Benoît explains that the slow progress of clinical trials during the COVID-19 pandemic is due to the difficulty of bringing patients into the hospital for exploratory trials. He also talks about the upcoming results of a trial that will be published in 2025 and holds the fate of the entire field in their hands.In this clip
From this podcast
The Peter Attia Drive Podcast
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Related Questions